Moffitt Cancer Center: Clinical Trial 20787

RESEARCH

Call Today

1-888-663-3488

COVID-19 Safety Precautions: Find the Latest Visitor and Mask Policies. Le arn More

Facebook

Twitter

Linkedin

Pinterest

Email

Clinical Trials Search

Back to Search Results

Clinical Trial 20787

Cancer Type: Multiple
Study Type: Other
NCT#:

Phase: N/A
Prinicipal Investigator: Smitha Pabbathi

Call 813-745-6100
or 1-800-679-0775 Learn More

Overview

Study Title

Health Literacy, Home Environmental Influence and Ethnicity and its Association to Adherence to Nutrition and Physical Exercise Guidelines in Adolescents and Young Adults Cancer Patients and Survivors: An Exploratory Study

Summary

Identify the role of health literacy, ethnicity and home environmental influence, in the adherence to nutrition and physical activity recommendations in adolescent and young adult (AYA) cancer patients and survivors

Objective

To assess AYA patients and survivors treated at Moffitt Cancer center barriers of adherence to nutrition and physical activity recommendations Explore the association of these barriers to adherence to nutrition and physical activity recommendations and its relation to environmental influences, including cultural factors. Explore the association of nutrition and physical activity behaviors, and its relation to health literacy

Treatments

Therapies

Medications

Inclusion Criteria

AYA cancer patients who have been diagnosed and are in the process of treatment, including Moffitt’s Total Cancer Care (TCC) consented patients.

AYA survivors who have completed treatment.

Patients diagnosed with any type of cancer, although we are focused on those with solid tumors or any type of leukemia diagnosis.

AYA patients diagnosed between the ages of 18 to 39.

Exclusion Criteria

AYA cancer patients or survivors with severe cognitive impairments

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.